10 synthetic peptides targeting 5 tumor asociated antigens | |
---|---|
Trade Name | |
Orphan Indication | Non-small cell lung cancer |
USA Market Approval | USA |
USA Designation Date | 2013-01-23 00:00:00 |
Sponsor | Orphan Synergy Europe Pharma (OSE Pharma);OSE Pharma Pepiniere Paris Sante Cochin, 29 bis rue du faubourg Saint Jacques;Paris |
Related Access Program